ARMP
Armata Pharmaceuticals Inc
3.70$
+3.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +16.1% | -45.3% | -55.8% | -100.0% | – | +2,554.8% | +443.6% | +23.1% | -17.8% | +14.2% | -5.2% | |
| – | – | – | +1.4% | +261.2% | +0.0% | +969.1% | +38.6% | +75.0% | -97.2% | +3,441.8% | -95.6% | |
| – | +16.1% | -122.9% | – | – | – | – | – | – | – | -922.4% | – | |
| – | -31.2% | +42.2% | -49.3% | +69.8% | +100.8% | +47.0% | +38.6% | +75.0% | -3.6% | +1.9% | -31.1% | |
| – | -2.0% | +25.4% | -9.8% | -24.9% | +62.5% | -14.0% | +4.0% | -10.2% | +56.6% | +13.2% | -5.9% | |
| – | -26.3% | +120.9% | -31.2% | -41.4% | +85.9% | -55.1% | +4.0% | -10.2% | +497.6% | -70.3% | +162.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -32.5% | -89.8% | -54.7% | +8,955.2% | +309.1% | +54.4% | |
| – | -102.5% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -89.9% | -145.3% | – | – | – | |
| – | -102.2% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.